Latest Breaking News On - Capricor board - Page 1 : comparemela.com

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

-Presented Statistically Significant 24-Month HOPE-2 Open Label Extension Data at the PPMD Annual Conference- -Enrollment Continues to Progress in HOPE-3, the Phase 3 Trial of CAP-1002 in Duchenne.

San diegoUnited statesLinda marbJoyce allaireYushi fengPaul auwaerterPhilipj gotwalsRaquel conaBusiness developmentNs pharma incGilead companyNippon shinyaku co ltdDivision of infectious diseasesCapricor company contactGlobenewswire incKen fisher center

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoYushi fengRaquel conaPaul auwaerterPhilipj gotwalsJoyce allaireLinda marbExosome platform technologyStrategic communicationsCapricor therapeutics incRegulatory affairsProgram managementNs pharma incGilead companyDivision of infectious diseases

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoYushi fengLinda marbRaquel conaJoyce allairePhilipj gotwalsPaul auwaerterCapricor therapeutics incExchange commission onNovartis institutes for biomedical researchProgram managementExosome platform technologyStrategic communicationsDuchenne muscular dystrophy programLifesci advisors